Gardner Lewis Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Gardner Lewis Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,517	Closed	-$6.18M	–	70
2023 Q4	$6.18M	Buy	+19,517	New	+$3.79M	2.09%	19

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Gardner Lewis Asset Management's KRTX Position: Q1 2024 in Review

Gardner Lewis Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 19,517 shares — an estimated $6.18M sold.

Gardner Lewis Asset Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $6.18M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Gardner Lewis Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Gardner Lewis Asset Management sold 19,517 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.18M.
Gardner Lewis Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Gardner Lewis Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $6.18M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2024, filed 13 May 2024.